Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex

Zhanguo Gao, Daniel Hwang, Fredly Bataille, Michael Lefevre, David York, Michael J. Quon, Jianping Ye

Research output: Contribution to journalArticle

524 Citations (Scopus)

Abstract

Insulin resistance contributes importantly to the pathophysiology of type 2 diabetes mellitus. One mechanism mediating insulin resistance may involve the phosphorylation of serine residues in insulin receptor substrate-1 (IRS-l), leading to impairment in the ability of IRS-1 to activate downstream phosphatidylinositol 3-kinase-dependent pathways. Insulin-resistant states and serine phosphorylation of IRS-1 are associated with the activation of the inhibitorκB kinase (IKK) complex. However, the precise molecular mechanisms by which IKK may contribute to the development of insulin resistance are not well understood. In this study, using phosphospecific antibodies against rat IRS-1 phosphorylated at Ser307 (equivalent to Ser312 in human IRS-1), we observed serine phosphorylation of IRS-1 in response to TNF-α or calyculin A treatment that paralleled surrogate markers for IKK activation. The phosphorylation of human IRS-1 at Ser3l2 in response to tumor necrosis factor-a was significantly reduced in cells pretreated with the IKK inhibitor 15 deoxy-prostaglandin J2 as well as in cells derived from IKK knock-out mice. We observed interactions between endogenous IRS-1 and IKK in intact cells using a co-immunoprecipitation approach. Moreover, this interaction between IRS-1 and IKK in the basal state was reduced upon IKK activation and increased serine phosphorylation of IRS-1. Data from in vitro kinase assays using recombinant IRS-1 as a substrate were consistent with the ability of IRS-1 to function as a direct substrate for IKK with multiple serine phosphorylation sites in addition to Ser312. Taken together, our data suggest that IRS-1 is a novel direct substrate for IKK and that phosphorylation of IRS-1 at Ser3l2 (and other sites) by IKK may contribute to the insulin resistance mediated by activation of inflammatory pathways.

Original languageEnglish (US)
Pages (from-to)48115-48121
Number of pages7
JournalJournal of Biological Chemistry
Volume277
Issue number50
DOIs
StatePublished - Dec 13 2002
Externally publishedYes

Fingerprint

Insulin Receptor Substrate Proteins
Phosphorylation
Serine
Phosphotransferases
Insulin Resistance
Insulin
Chemical activation
Substrates
Phospho-Specific Antibodies
Phosphatidylinositol 3-Kinase
Medical problems
Immunoprecipitation
Knockout Mice
Type 2 Diabetes Mellitus
Rats
Assays
Tumor Necrosis Factor-alpha
Biomarkers

ASJC Scopus subject areas

  • Biochemistry

Cite this

Gao, Z., Hwang, D., Bataille, F., Lefevre, M., York, D., Quon, M. J., & Ye, J. (2002). Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex. Journal of Biological Chemistry, 277(50), 48115-48121. https://doi.org/10.1074/jbc.M209459200

Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex. / Gao, Zhanguo; Hwang, Daniel; Bataille, Fredly; Lefevre, Michael; York, David; Quon, Michael J.; Ye, Jianping.

In: Journal of Biological Chemistry, Vol. 277, No. 50, 13.12.2002, p. 48115-48121.

Research output: Contribution to journalArticle

Gao, Z, Hwang, D, Bataille, F, Lefevre, M, York, D, Quon, MJ & Ye, J 2002, 'Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex', Journal of Biological Chemistry, vol. 277, no. 50, pp. 48115-48121. https://doi.org/10.1074/jbc.M209459200
Gao, Zhanguo ; Hwang, Daniel ; Bataille, Fredly ; Lefevre, Michael ; York, David ; Quon, Michael J. ; Ye, Jianping. / Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex. In: Journal of Biological Chemistry. 2002 ; Vol. 277, No. 50. pp. 48115-48121.
@article{e51448a9e7044fbebf8e2537ee98b5d1,
title = "Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex",
abstract = "Insulin resistance contributes importantly to the pathophysiology of type 2 diabetes mellitus. One mechanism mediating insulin resistance may involve the phosphorylation of serine residues in insulin receptor substrate-1 (IRS-l), leading to impairment in the ability of IRS-1 to activate downstream phosphatidylinositol 3-kinase-dependent pathways. Insulin-resistant states and serine phosphorylation of IRS-1 are associated with the activation of the inhibitorκB kinase (IKK) complex. However, the precise molecular mechanisms by which IKK may contribute to the development of insulin resistance are not well understood. In this study, using phosphospecific antibodies against rat IRS-1 phosphorylated at Ser307 (equivalent to Ser312 in human IRS-1), we observed serine phosphorylation of IRS-1 in response to TNF-α or calyculin A treatment that paralleled surrogate markers for IKK activation. The phosphorylation of human IRS-1 at Ser3l2 in response to tumor necrosis factor-a was significantly reduced in cells pretreated with the IKK inhibitor 15 deoxy-prostaglandin J2 as well as in cells derived from IKK knock-out mice. We observed interactions between endogenous IRS-1 and IKK in intact cells using a co-immunoprecipitation approach. Moreover, this interaction between IRS-1 and IKK in the basal state was reduced upon IKK activation and increased serine phosphorylation of IRS-1. Data from in vitro kinase assays using recombinant IRS-1 as a substrate were consistent with the ability of IRS-1 to function as a direct substrate for IKK with multiple serine phosphorylation sites in addition to Ser312. Taken together, our data suggest that IRS-1 is a novel direct substrate for IKK and that phosphorylation of IRS-1 at Ser3l2 (and other sites) by IKK may contribute to the insulin resistance mediated by activation of inflammatory pathways.",
author = "Zhanguo Gao and Daniel Hwang and Fredly Bataille and Michael Lefevre and David York and Quon, {Michael J.} and Jianping Ye",
year = "2002",
month = "12",
day = "13",
doi = "10.1074/jbc.M209459200",
language = "English (US)",
volume = "277",
pages = "48115--48121",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "50",

}

TY - JOUR

T1 - Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex

AU - Gao, Zhanguo

AU - Hwang, Daniel

AU - Bataille, Fredly

AU - Lefevre, Michael

AU - York, David

AU - Quon, Michael J.

AU - Ye, Jianping

PY - 2002/12/13

Y1 - 2002/12/13

N2 - Insulin resistance contributes importantly to the pathophysiology of type 2 diabetes mellitus. One mechanism mediating insulin resistance may involve the phosphorylation of serine residues in insulin receptor substrate-1 (IRS-l), leading to impairment in the ability of IRS-1 to activate downstream phosphatidylinositol 3-kinase-dependent pathways. Insulin-resistant states and serine phosphorylation of IRS-1 are associated with the activation of the inhibitorκB kinase (IKK) complex. However, the precise molecular mechanisms by which IKK may contribute to the development of insulin resistance are not well understood. In this study, using phosphospecific antibodies against rat IRS-1 phosphorylated at Ser307 (equivalent to Ser312 in human IRS-1), we observed serine phosphorylation of IRS-1 in response to TNF-α or calyculin A treatment that paralleled surrogate markers for IKK activation. The phosphorylation of human IRS-1 at Ser3l2 in response to tumor necrosis factor-a was significantly reduced in cells pretreated with the IKK inhibitor 15 deoxy-prostaglandin J2 as well as in cells derived from IKK knock-out mice. We observed interactions between endogenous IRS-1 and IKK in intact cells using a co-immunoprecipitation approach. Moreover, this interaction between IRS-1 and IKK in the basal state was reduced upon IKK activation and increased serine phosphorylation of IRS-1. Data from in vitro kinase assays using recombinant IRS-1 as a substrate were consistent with the ability of IRS-1 to function as a direct substrate for IKK with multiple serine phosphorylation sites in addition to Ser312. Taken together, our data suggest that IRS-1 is a novel direct substrate for IKK and that phosphorylation of IRS-1 at Ser3l2 (and other sites) by IKK may contribute to the insulin resistance mediated by activation of inflammatory pathways.

AB - Insulin resistance contributes importantly to the pathophysiology of type 2 diabetes mellitus. One mechanism mediating insulin resistance may involve the phosphorylation of serine residues in insulin receptor substrate-1 (IRS-l), leading to impairment in the ability of IRS-1 to activate downstream phosphatidylinositol 3-kinase-dependent pathways. Insulin-resistant states and serine phosphorylation of IRS-1 are associated with the activation of the inhibitorκB kinase (IKK) complex. However, the precise molecular mechanisms by which IKK may contribute to the development of insulin resistance are not well understood. In this study, using phosphospecific antibodies against rat IRS-1 phosphorylated at Ser307 (equivalent to Ser312 in human IRS-1), we observed serine phosphorylation of IRS-1 in response to TNF-α or calyculin A treatment that paralleled surrogate markers for IKK activation. The phosphorylation of human IRS-1 at Ser3l2 in response to tumor necrosis factor-a was significantly reduced in cells pretreated with the IKK inhibitor 15 deoxy-prostaglandin J2 as well as in cells derived from IKK knock-out mice. We observed interactions between endogenous IRS-1 and IKK in intact cells using a co-immunoprecipitation approach. Moreover, this interaction between IRS-1 and IKK in the basal state was reduced upon IKK activation and increased serine phosphorylation of IRS-1. Data from in vitro kinase assays using recombinant IRS-1 as a substrate were consistent with the ability of IRS-1 to function as a direct substrate for IKK with multiple serine phosphorylation sites in addition to Ser312. Taken together, our data suggest that IRS-1 is a novel direct substrate for IKK and that phosphorylation of IRS-1 at Ser3l2 (and other sites) by IKK may contribute to the insulin resistance mediated by activation of inflammatory pathways.

UR - http://www.scopus.com/inward/record.url?scp=0037073679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037073679&partnerID=8YFLogxK

U2 - 10.1074/jbc.M209459200

DO - 10.1074/jbc.M209459200

M3 - Article

C2 - 12351658

AN - SCOPUS:0037073679

VL - 277

SP - 48115

EP - 48121

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 50

ER -